β-Adrenoceptor antagonists in elderly patients with chronic heart failure: therapeutic potential of third-generation agents
AJS Coats - Drugs & aging, 2006 - Springer
Chronic heart failure (CHF) is a common and disabling condition with an incidence and
prevalence that increase sharply with age. The median age of presentation of new heart …
prevalence that increase sharply with age. The median age of presentation of new heart …
β-Adrenoceptor Antagonists in Elderly Patients with Chronic Heart Failure: Therapeutic Potential of Third-Generation Agents.
AJS Coats - Drugs & Aging, 2006 - search.ebscohost.com
Chronic heart failure (CHF) is a common and disabling condition with an incidence and
prevalence that increase sharply with age. The median age of presentation of new heart …
prevalence that increase sharply with age. The median age of presentation of new heart …
[引用][C] Adrenoceptor Antagonists in Elderly Patients with Chronic Heart Failure
AJS Coats - Drugs and Aging, 2006 - hero.epa.gov
Beta-adrenoceptor antagonists in elderly patients with chronic heart failure: therapeutic potential of third-generation agents.
AJ Coats - Drugs & Aging, 2006 - europepmc.org
Chronic heart failure (CHF) is a common and disabling condition with an incidence and
prevalence that increase sharply with age. The median age of presentation of new heart …
prevalence that increase sharply with age. The median age of presentation of new heart …
[引用][C] Β-adrenoceptor antagonists in elderly patients with chronic heart failure: Therapeutic potential of third-generation agents
AJS COATS - Drugs & aging, 2006 - pascal-francis.inist.fr
Β-adrenoceptor antagonists in elderly patients with chronic heart failure : Therapeutic
potential of third-generation agents CNRS Inist Pascal-Francis CNRS Pascal and Francis …
potential of third-generation agents CNRS Inist Pascal-Francis CNRS Pascal and Francis …
Beta-adrenoceptor antagonists in elderly patients with chronic heart failure: Therapeutic potential of third-generation agents
AJS Coats - Drugs & Aging, 2006 - research-portal.uea.ac.uk
Chronic heart failure (CHF) is a common and disabling condition with an incidence and
prevalence that increase sharply with age. The median age of presentation of new heart …
prevalence that increase sharply with age. The median age of presentation of new heart …
Beta-adrenoceptor antagonists in elderly patients with chronic heart failure: therapeutic potential of third-generation agents
AJS Coats - Drugs & aging, 2006 - pubmed.ncbi.nlm.nih.gov
Chronic heart failure (CHF) is a common and disabling condition with an incidence and
prevalence that increase sharply with age. The median age of presentation of new heart …
prevalence that increase sharply with age. The median age of presentation of new heart …
[beta]-adrenoceptor antagonists in elderly patients with chronic heart failure: therapeutic potential of third-generation agents
AJS Coats - Drugs & Aging, 2006 - go.gale.com
Chronic heart failure (CHF) is a common and disabling condition with an incidence and
prevalence that increase sharply with age. The median age of presentation of new heart …
prevalence that increase sharply with age. The median age of presentation of new heart …
Beta-adrenoceptor antagonists in elderly patients with chronic heart failure: Therapeutic potential of third-generation agents
AJS Coats - Drugs & Aging, 2006 - ueaeprints.uea.ac.uk
Chronic heart failure (CHF) is a common and disabling condition with an incidence and
prevalence that increase sharply with age. The median age of presentation of new heart …
prevalence that increase sharply with age. The median age of presentation of new heart …
Beta-adrenoceptor antagonists in elderly patients with chronic heart failure: therapeutic potential of third-generation agents.
AJS Coats - Drugs & Aging, 2006 - search.ebscohost.com
Chronic heart failure (CHF) is a common and disabling condition with an incidence and
prevalence that increase sharply with age. The median age of presentation of new heart …
prevalence that increase sharply with age. The median age of presentation of new heart …